期刊
TRANSFUSION AND APHERESIS SCIENCE
卷 37, 期 2, 页码 191-200出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.transci.2007.08.003
关键词
inflammatory bowel disease; granulocytes; proinfammatory CD14(+)CD16(+) monocytes; selective leukocytapheresis; regulatory CD4(+)CD25(+)Foxp3 T cells; Adacolumn
类别
The inference that granulocytes and monocytes/macrophages (GM) are part of the immunopathogenesis of inflammatory bowel disease (IBD) and hence should be targets of therapy stems from observations of elevated, and activated GM in patients with IBD. The Adacolumn can selectively deplete GM by adsorption (GMA) and in patients with IBD, GMA has been associated with significant clinical efficacy together with sustained suppression of inflammatory cytokine profiles. Additionally, GMA depleted proinflammatory CD 14(+)CD 16(+) monocytes and was followed by an increase in CD4(+) T lymphocytes including the regulatory CD4(+)CD25(high+)Foxp3 phenotype. Hence, GMA could be a non-pharmacologic therapy for IBD with potential to spare steroids and other unsafe pharmacologic preparations. (C) 2007 Published by Elsevier Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据